Vir Biotechnology, Inc.VIRNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-3.0%
5Y CAGR+7.4%
Year-over-Year Change
Research and development spending
3Y CAGR
-3.0%/yr
vs +47.5%/yr prior
5Y CAGR
+7.4%/yr
Recent deceleration
Acceleration
-50.5pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $432.80M | -14.6% |
| 2024 | $506.50M | -12.6% |
| 2023 | $579.72M | +22.1% |
| 2022 | $474.65M | +5.9% |
| 2021 | $448.01M | +48.1% |
| 2020 | $302.41M | +103.7% |
| 2019 | $148.47M | +48.1% |
| 2018 | $100.23M | +60.3% |
| 2017 | $62.51M | - |